# Prevail Therapeutics Inc. — Form D

Prevail Therapeutics Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-14. The offering totals $65.0M, of which $57.0M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2018-03-14
- Form: D
- Accession: 0001714798-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $57.0M
- Remaining: $8.0M
- Investors: 15
- Date of first sale: 2018-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-307751

## Issuer

- Name: Prevail Therapeutics Inc.
- CIK: 0001714798
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 430 EAST 29TH STREET, SUITE 940, NEW YORK, NY, 10016
- Phone: 917-336-9310

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| ASA ABELIOVICH | Director | NEW YORK, NY |
| Mona Ashiya | Director | New York, NY |
| CARL GORDON | Director | SAN DIEGO, CA |
| Peter Thompson | Director | Chanhassen, MN |
| ASA ABELIOVICH | Executive Officer | NEW YORK, NY |

## More

- [CIK 1714798 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1714798&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001714798-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.